PMID- 11156888 OWN - NLM STAT- MEDLINE DCOM- 20010524 LR - 20190623 IS - 1524-4539 (Electronic) IS - 0009-7322 (Linking) VI - 103 IP - 5 DP - 2001 Feb 6 TI - Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha. PG - 743-9 AB - BACKGROUND: It has been reported that tumor necrosis factor-alpha (TNF-alpha) is expressed in the heart with viral myocarditis and that its expression aggravates the condition. The pathophysiological effects of TNF-alpha on viral myocarditis, however, have not been fully elucidated. METHODS AND RESULTS: To investigate the role of TNF-alpha in the progression of viral myocarditis, we used TNF-alpha gene-deficient mice (TNF-alpha(-/-)) and induced acute myocarditis by infection with encephalomyocarditis virus (EMCV). The survival rate of TNF-alpha(-/-) mice after EMCV infection was significantly lower than that of TNF-alpha(+/+) mice (0% versus 67% on day 14). Injection of recombinant human TNF-alpha (0.2 to 4.0 microg/mouse IV) improved the survival of TNF-alpha(-/-) mice in a dose-dependent manner, indicating that TNF-alpha is essential for protection against viral myocarditis. The levels of viral titer and viral genomic RNA of EMCV in the myocardium were significantly higher in TNF-alpha(-/-) than in TNF-alpha(+/+) mice. Histopathological examination showed that the inflammatory changes of the myocardium were less marked in TNF-alpha(-/-) than in TNF-alpha(+/+) mice. Immunohistochemical analysis revealed that the levels of immunoreactivity of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the myocardium were decreased in TNF-alpha(-/-) mice compared with TNF-alpha(+/+) mice. CONCLUSIONS: These observations suggested that TNF-alpha is necessary for adhesion molecule expression and to recruit leukocytes to inflammatory sites, and thus, the lack of this cytokine resulted in failure of elimination of infectious agents. We concluded that TNF-alpha plays a protective role in the acute stage of viral myocarditis. FAU - Wada, H AU - Wada H AD - Department of Laboratory Medicine, Gifu University School of Medicine, Gifu, Japan. wadah@cc.gifu-u.ac.jp FAU - Saito, K AU - Saito K FAU - Kanda, T AU - Kanda T FAU - Kobayashi, I AU - Kobayashi I FAU - Fujii, H AU - Fujii H FAU - Fujigaki, S AU - Fujigaki S FAU - Maekawa, N AU - Maekawa N FAU - Takatsu, H AU - Takatsu H FAU - Fujiwara, H AU - Fujiwara H FAU - Sekikawa, K AU - Sekikawa K FAU - Seishima, M AU - Seishima M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Circulation JT - Circulation JID - 0147763 RN - 0 (RNA, Messenger) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 1.1.1.27 (L-Lactate Dehydrogenase) RN - EC 2.6.1.2 (Alanine Transaminase) RN - EC 2.7.3.2 (Creatine Kinase) SB - IM CIN - Circulation. 2001 Feb 6;103(5):626-9. PMID: 11156870 MH - Acute Disease MH - Alanine Transaminase/metabolism MH - Analysis of Variance MH - Animals MH - Blood Urea Nitrogen MH - Creatine Kinase/metabolism MH - Disease Models, Animal MH - Female MH - Immunohistochemistry MH - L-Lactate Dehydrogenase/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Myocarditis/enzymology/metabolism/*prevention & control/virology MH - RNA, Messenger/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Tumor Necrosis Factor-alpha/metabolism/*therapeutic use MH - Viral Load EDAT- 2001/02/07 11:00 MHDA- 2001/05/26 10:01 CRDT- 2001/02/07 11:00 PHST- 2001/02/07 11:00 [pubmed] PHST- 2001/05/26 10:01 [medline] PHST- 2001/02/07 11:00 [entrez] AID - 10.1161/01.cir.103.5.743 [doi] PST - ppublish SO - Circulation. 2001 Feb 6;103(5):743-9. doi: 10.1161/01.cir.103.5.743.